The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUDG.L Share News (UDG)

  • There is currently no data for UDG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UDG Healthcare Appoints New Chair, Guides For Annual Profit Drop

Wed, 05th Aug 2020 10:54

(Alliance News) - UDG Healthcare PLC said Wednesday it expects to report a decline in earnings for its current financial year, as parts of its operations have been affected by the ongoing Covid-19 pandemic.

Also, the Dublin-based healthcare services provider announced the appointment of Non-Executive Director Shane Cooke as chair with effect from October 1.

He will be replacing Peter Gray, who is stepping down at the end of September after eight years since 2012.

Cooke's most recent executive role was as president of mental health-focused biopharmaceutical company Alkermes Inc for seven years from 2011 to 2018.

"Following a robust and thorough selection process led by our senior independent director, Myles Lee, I am delighted to be handing over to Shane in October. His breadth of experience, particularly in the US healthcare market, will be a great asset in guiding the board of UDG as it continues to chart its strategic course," said Gray said.

In addition, the group has appointed Ryan Quigley as chief operating officer with effect on September 14.

For the third quarter to the end of June, UDG said pretax profit was below the same period the prior year. Its Ashfield business made a much weaker performance, as in-field activities were the most impacted by Covid-19.

However, the Sharp unit traded very strongly, with growth achieved in all parts of the business through strong demand, improving mix effect and operational improvements.

Although UDG's profit for the third quarter alone was down year-on-year, for the nine-month period pretax profit was higher, due to contributions from acquisitions made in 2019, and underlying growth.

Looking ahead, UDG has reinstated its financial guidance for the year ending September 30, and is expecting to report adjusted diluted earnings per share between 43 US cents and 45 US cents.

This reflects a 7.1% to 11% drop from 48.44 US cents the year before.

UDG will publish its annual results on November 24.

Shares in UDG Healthcare were up 5.8% at 748.62 pence on Wednesday in London.

By Dayo Laniyan; dayolaniyan@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
24 Nov 2020 10:12

UDG Healthcare Raises Dividend As Full-Year Earnings Top Guidance

UDG Healthcare Raises Dividend As Full-Year Earnings Top Guidance

Read more
24 Nov 2020 08:09

UDG Healthcare posts stronger than expected full-year profits

(Sharecast News) - UDG Healthcare posted a sharper than expected rise in full-year profits on the back of "strong" growth at its Sharp unit, which focuses on contract clinical, manufacturing and packaging, and is heavily involved in efforts to squash Covid-19.

Read more
17 Nov 2020 16:06

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
13 Nov 2020 09:39

UK BROKER RATINGS SUMMARY: Barclays Raises Whitbread To Overweight

UK BROKER RATINGS SUMMARY: Barclays Raises Whitbread To Overweight

Read more
11 Nov 2020 15:37

FTSE 250 movers: Energy and Financials wanted, Meggitt downgraded

(Sharecast News) - Energy and Financials paced gains on the second-tier index on Wednesday as investors continued to shift towards cyclicals after Pfizer and BioNTech announced two days before a greater than 90% efficacy for the Covid-19 vaccine.

Read more
11 Nov 2020 12:21

RBC Capital upgrades UDG Healthcare to 'outperform'

(Sharecast News) - RBC Capital Markets upgraded its rating on shares of UDG Healthcare on Wednesday to 'outperform' from 'sector perform' and hiked the price target to 880p from 800p, saying it was "time to get more positive".

Read more
11 Nov 2020 11:18

UK WINNERS & LOSERS SUMMARY: IAG Boosted By Two Broker Upgrades

UK WINNERS & LOSERS SUMMARY: IAG Boosted By Two Broker Upgrades

Read more
9 Nov 2020 10:58

UK WINNERS & LOSERS SUMMARY: Countrywide Jumps 43% On Takeover Offer

UK WINNERS & LOSERS SUMMARY: Countrywide Jumps 43% On Takeover Offer

Read more
9 Nov 2020 09:57

UK BROKER RATINGS SUMMARY: Jefferies And Shore Say Hold RSA Insurance

UK BROKER RATINGS SUMMARY: Jefferies And Shore Say Hold RSA Insurance

Read more
29 Oct 2020 16:33

UK EXECUTIVE CHANGE SUMMARY: Biome Tech Hires Former Filtronic CEO

UK EXECUTIVE CHANGE SUMMARY: Biome Tech Hires Former Filtronic CEO

Read more
1 Oct 2020 09:09

UDG Appoints Aerami Therapeutics CEO To Board; Cooke Becomes Chair

UDG Appoints Aerami Therapeutics CEO To Board; Cooke Becomes Chair

Read more
17 Aug 2020 10:27

Ex-divs to take 7.7 points off FTSE 100 on 20 August

By Joice Alves LONDON, Aug 17 (Reuters) - The following FTSE 100 companies will go ex-dividend on Thursday, after which investors will no longer qualify for the latest dividend payout. According to Reuters calculations at current ma...

Read more
5 Aug 2020 07:48

LONDON MARKET PRE-OPEN: Legal & General Dividend Steady, Profit Drops

LONDON MARKET PRE-OPEN: Legal & General Dividend Steady, Profit Drops

Read more
5 Aug 2020 07:41

UDG Healthcare reinstates guidance, declares interim dividend

(Sharecast News) - UDG Healthcare reinstated its guidance and declared an interim dividend on Wednesday, as its trading visibility improved with the reopening of a number of its markets.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.